← Back to Search

Other

Dietary Fatty Acid Profiles for Type 2 Diabetes (METAc Trial)

N/A
Recruiting
Led By Alain Veilleux, PhD
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Men and women aged between 45 and 65 years, menopaused women
Men and women aged between 45 and 65 years, menopaused women ;
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 7 days
Awards & highlights

METAc Trial Summary

This trial looks at how fatty acids affect the body's production of dietary metabolites in people with and without obesity and T2D.

Who is the study for?
This trial is for men and women aged 45-65, with a BMI of 20-35 kg/m², who are generally healthy and have a moderate diet quality. They must understand French and have internet access. It's not for smokers, heavy drinkers, recent antibiotic users, those on omega-3 supplements or with significant weight changes recently.Check my eligibility
What is being tested?
The study looks at how different types of fats in meals (saturated vs. polyunsaturated fatty acids) affect the production of certain metabolites by gut bacteria in people with/without obesity and Type 2 diabetes.See study design
What are the potential side effects?
Since this is a nutritional intervention focusing on meal content rather than medication or invasive procedures, side effects may be minimal but could include digestive discomfort depending on individual reactions to dietary fat changes.

METAc Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 45 and 65 years old, or I am a woman who has gone through menopause.
Select...
I am between 45 and 65 years old, or I am a woman who has gone through menopause.

METAc Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~7 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Fasting and postprandial lipid metabolite production in response to dietary lipid intervention in abdominal obesity and type 2 diabetes
Secondary outcome measures
Gut microbiota in response to a 2 day dietary lipid intervention in abdominal obesity and type 2 diabetes

METAc Trial Design

1Treatment groups
Experimental Treatment
Group I: SingleExperimental Treatment1 Intervention
All participating subjects will undergo 3 feeding phases : 3 days of a run-in diet, 2 days of a polyunsaturated fatty acid (PUFA) diet and 2 days of a saturated fatty acid (SFA) diet.

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
418 Previous Clinical Trials
172,222 Total Patients Enrolled
Alain Veilleux, PhDPrincipal InvestigatorLaval University
1 Previous Clinical Trials
204 Total Patients Enrolled

Media Library

Nutritional intervention (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05917132 — N/A
Abdominal Obesity Research Study Groups: Single
Abdominal Obesity Clinical Trial 2023: Nutritional intervention Highlights & Side Effects. Trial Name: NCT05917132 — N/A
Nutritional intervention (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05917132 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what population does this research opportunity apply?

"Applicants for this medical trial must between 45 and 65 years old, displaying abdominal obesity. The current recruitment goal is to accept 60 people into the study."

Answered by AI

Is the recruitment period of this medical experiment still open?

"At this point, according to clinicaltrials.gov, the trial is not enrolling new candidates as it was posted on June 12th 2023 and last modified 15 days later. However, 887 other trials are currently searching for volunteers."

Answered by AI

Is this clinical trial limited to individuals under 45, or can people of a more advanced age participate?

"The minimum age for this clinical trial is 45 years old, with the upper limit set at 65."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Production of Gut Microbiota-Derived Metabolites in Response to Different Fatty Acid Profiles
Alain Veilleux 2023. "Production of Gut Microbiota-Derived Metabolites in Response to Different Fatty Acid Profiles". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05917132.
~5 spots leftby Jun 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top